Sareum gets US patent on Pyrazolopyridines to treat Cancer

Sareum, which is a specialist in cancer drug discovery, received a patent from US Patent and Trademark Office for compounds (Pyrazolopyridines) that can inhibit CHK1 kinase enzyme and thereby helping in cancer treatment. Sareum deals with the discovery of small…

More Details
Ranbaxy at back foot: Punjab’s plant (4th in India) banned by FDA

Ranbaxy Laboratories which is one of the largest and reputed companies of India, exports its drugs throughout the world. U.S. is the main consumer of generic drugs made at Ranbaxy but due to one defect found in the drugs of…

More Details
Efavirenz (HIV Drug) case: Bristol (BMS) won over Mylan Pharma

Bristol Meyers Squibb (BMS), manufacturers of Efavirenz (patented drug for HIV) won over the companies named Mylan Pharmaceuticals Inc. and Mylan Laboratories Ltd. that made generic version of Efavirenz that is Sustiva. The companies filed an application in court for…

More Details
Pharmaceutical Companies shift from Small Molecule Drugs to Biotech Drugs

Recently, the Tufts University’s Center for the Study of Drug Development (CSDD) released an interesting report revealing the dramatic shift of pharmaceutical companies from manufacturing small molecule drugs to a large number of biotechnology drugs. The report shows that in…

More Details
ViaCyte: Regenerative Medicine and Cell Therapy Derived from Stem Cells

ViaCyte Inc. is emerging as a leader in regenerative medicine and is all set to develop a new approach for the treatment of major diseases using cell therapy derived from stem cells. The company was granted 28 patents in 2011-2013…

More Details
Unaffordable Life Saving Drug (Linezolid by Pfizer) Leaves TB Patients Struggling in South Africa

South Africa could not keep up with the treatment for Drug resistant Tuberculosis (TB), which has affected thousands of people in the country. Many of the sufferers would die and the death would be horrible and slow. Not only this,…

More Details
Indian Pharma Landscape: Growing Presence in International Market

Indian pharmaceutical companies have increased their expenditure in their research and development section by 19.7%. The purpose of this increment is not to discover new drugs but to create more cost effective generic drugs. More investment may make them a…

More Details
Victory of Generic Companies: Benefit to Consumers

Conflicts between the innovators and generic companies have increased to a great extent and the latest example of the same is the one between Novartis and Merck-Glenmark. These conflicts came into picture when Mylan filed an Abbreviated New Drug Application…

More Details
X